Provision of IMRT in the UK. Part 1: A review of planning, delivery and related technologies

Journal of Radiotherapy in Practice

Volumn 3, Issue 4, 2003, Pages 175-180

  Baker, Colin R ^a   Hardy, V ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Intensity modulated radiotherapy; Radiotherapy related process and technologies

Indexed keywords

COMPUTER ASSISTED RADIOTHERAPY; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; MEDICAL TECHNOLOGY; PROTON RADIATION; QUALITY CONTROL; RADIOBIOLOGY; RADIOLOGY DEPARTMENT; REVIEW; TREATMENT PLANNING; UNITED KINGDOM;

EID: 31144454792     PISSN: 14603969     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1460396903000529     Document Type: Review

References (33)

1. Baker C, Hardy V. Provision of IMRT in the UK. Part 2: Current levels, planned expansion and obstacles to implementation. Journal of Radiotherapy in Practice 2003; 3(4): 15-18.
2. Saw CB, Komanduri MA, Zhen W, Yoe-sein M, Pillai S, Enke CA. Clinical implementation of intensity-modulated radiation therapy. Med Dosim 2002; 27(2): 161-169.
3. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002; 52(1): 224-235.
4. Amer AM, Mott J, Mackay RI, et al. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2003; 56(1): 199-207.
5. Sanchez-Nieto B, Nahum AE. Bioplan: Software for the biological evaluation of radiotherapy treatment plans. Med Dosim 2000; 25(2): 71-76.
6. MacKay RI, Hendry JH, Moore CJ, Williams PC, Read G. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Brit J Radiol 1997; 70: 517-526.
7. Buffa FM, Davidson SE, Hunter RD, Nahum AE, West CML. Incorporating biologic measurements (SF2, CFE) into a tumour control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50(5): 1113-1122.
8. Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP. Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Brit J Radiol 2002; 75: 151-161.
9. Niermierko A, Goitein M. Implementation of a model for estimating tumour control probability for an inhomogeneously irradiated tumour. Rad Oncol 1993; 29: 140-147.
10. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects on inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993; 38: 653-666.
11. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21(1): 123-135.
12. Kallman P, Ågren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992; 62(2): 249-262.
13. Wang JZ, Guerrero M, Li XA. How low is the ratio for prostate cancer? Int J Radiat Oncol Biol Phys 2003; 55(1): 194-203.
14. Esch AV, Bohsung J, Sorvari P, et al. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: Experience from five radiotherapy departments. Rad Oncol 2002; 65: 53-70.
15. Chuang CF, Verhey LJ, Xia P. Investigation of the use of MOSFET for clinical IMRT dosimetric verification. Med Phys 2002; 29(6): 1109-1115.
16. Burman C, Chui C-S, Kutcher G, et al. Planning, delivery and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 39(4): 863-873.
17. Kirby MC, Williams PC. The use of an electronic portal imaging device for exit dosimetry and quality control measurements. Int J Radiat Oncol Biol Phys 1995; 31(3): 593-603.
18. Chandra A, Dong L, Huang E, Kuban DA, O'Neil L, Rosen I, Pollack A. Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys 2003; 56(2): 436-47.
19. Niermierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997; 24(1): 102-110.
20. Seppenwoolde Y, Lebesque JV, De Jaeger K, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2003; 55(3): 724-735.
21. Fenwick JD, Nahum AE. Impact of dose-distribution uncertainties on rectal NTCP modelling I: Uncertainty estimates. Med Phys 2000; 28(4): 560-569.
22. Van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002; 52(5): 1407-1422.
23. Saw CB, Yakoob R, Enke CA, et al. Immobilization devices for intensity-modulated radiation therapy (IMRT). Med Dosim 2001; 26(1): 71-77.
24. Shirato H, Harada T, Harabayashi T, et al. Feasibility of insertion/ implanation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumour tracking in radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56(1): 240-247.
25. Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56(1): 89-105.
26. Groh BA, Siewerdsen JH, Drake DG, Wong JW, Jaffray DA. A performance comparison of flat-panel imager-based MV and kV cone-beam CT. Med Phys 2002; 29(6): 967-975.
27. Kini VR, Vedam SS, Keall PJ, Patil S, Chen C, Mohan R. Patient training in respiratory-gated radiotherapy. Med Dosim 2003; 28(1): 7-11.
28. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993; 20: 1709-1719.
29. Verellen D, Linthout N, Van Den Berge D, Bel A, Storme G. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. Int J Radiat Oncol Biol Phys 1997; 39(1): 99-114.
30. Xing L, Cotrutz C, Hunjan S, Boyer AL, Adalsteinsson E, Spielman D. Inverse planning for functional image-guided intensity-modulated radiation therapy. Phys Med Biol 2002; 47(20): 3567-3578.
31. Fowler JF. What can we expect from dose escalation using proton beams? Clin Onc 2003; 15: S10-S15.
32. ICRU Report 50. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU 1993; Bethesda, Maryland.
33. ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). ICRU 1999; Bethesda, Maryland.